This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
⚠️ Warnings
• Delafloxacin should be used with caution in patients with rheumatoid arthritis as delafloxacin is associated with the risk of tendinitis and tendon rupture.
• Patients are advised to report to the physician when they experience symptoms of peripheral neuropathy such as loss of sensation, pain, burning, tingling sensation or numbness, particularly in diabetics.
• Delafloxacin should be used cautiously in patients with brain disorders because it may induce or aggravate the existing central nervous system effects (convulsions, hallucination, depression, agitation, nightmares, anxiety, increased intracranial pressure or suicidal thoughts)
• Patients should be monitored for muscle weakness as delafloxacin may worsen myasthenia gravis.
• Allergic reaction or Clostridium difficile associated diarrhea are reported in patients on delafloxacin therapy and should be treated accordingly.
• Delafloxacin should be discontinued when severe adverse effects occur during the therapy and patients should be monitored regularly.